Mechanistic insights into the activity of SARS-CoV-2 RNA polymerase inhibitors using single-molecule FRET
Nucleic Acids Research · 22.04.2025 · 53 (8)
DOI: 10.1093/nar/gkaf351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 29.04.2025. Verfasst von Danielle Groves und 8 weiteren Autor:innen. Beteiligte Einrichtung: Warwick Medical School, University of Warwick, Coventry, CV4 7AL, United Kingdom. Hauptthemen laut MEDLINE: Fluorescence Resonance Energy Transfer, SARS-CoV-2, Coronavirus RNA-Dependent RNA Polymerase, Antiviral Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Society Dorothy Hodgkin Research Fellowship, Medical Research Council.
Abstract (Originalsprache)
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has resulted in significant global mortality, with over 7 million cases reported. Despite extensive research and high vaccination rates, highly mutated forms of the virus continue to circulate. It is therefore important to understand the viral lifecycle and the precise molecular mechanisms underlying SARS-CoV-2 replication. To address this, we developed a single-molecule Förster resonance energy transfer (smFRET) assay to directly visualize and analyse in vitro RNA synthesis by the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp). We purified the minimal replication complex, comprising nsp12, nsp7, and nsp8, and combined it with fluorescently labelled RNA substrates, enabling real-time monitoring of RNA primer elongation at the single-molecule level. This platform allowed us to investigate the mechanisms of action of key inhibitors of SARS-CoV-2 replication. In particular, our data provides evidence for remdesivir’s mechanism of action, which involves polymerase stalling and subsequent chain termination dependent on the concentration of competing nucleotide triphosphates. Our study demonstrates the power of smFRET to provide dynamic insights into SARS-CoV-2 replication, offering a valuable tool for antiviral screening and mechanistic studies of viral RdRp activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Warwick Medical School, University of Warwick, Coventry, CV4 7AL, United Kingdom.
- Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3PU, United Kingdom.
- School of Life Sciences, University of Warwick, Coventry, CV4 7AL, United Kingdom.
ORCID-Profile: Haitian Fan, Ervin Fodor, Nicole C Robb
Förderung
- Royal Society Dorothy Hodgkin Research Fellowship
- Medical Research Council
Zitieren
APA
Groves, D., Cunnison, R., McMahon, A., Fan, H., Sharps, J., Deng, A., Keown, J. R., Fodor, E., & Robb, N. C. (2025). Mechanistic insights into the activity of SARS-CoV-2 RNA polymerase inhibitors using single-molecule FRET. Nucleic Acids Research, 53(8). https://doi.org/10.1093/nar/gkaf351
Vancouver
Groves D, Cunnison R, McMahon A, Fan H, Sharps J, Deng A, et al. Mechanistic insights into the activity of SARS-CoV-2 RNA polymerase inhibitors using single-molecule FRET. Nucleic Acids Research. 2025;53(8). doi:10.1093/nar/gkaf351
BibTeX
@article{Groves2025,
author = {Groves, Danielle and Cunnison, Rory and McMahon, Andrew and Fan, Haitian and Sharps, Jane and Deng, Adrian and Keown, Jeremy R and Fodor, Ervin and Robb, Nicole C},
title = {Mechanistic insights into the activity of SARS-CoV-2 RNA polymerase inhibitors using single-molecule FRET},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {8},
doi = {10.1093/nar/gkaf351}
}
EUVIMED